Sigma Planning Corp’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-23,575
| Closed | -$157K | – | 1311 |
|
|
2025
Q1 | $157K | Buy |
23,575
+200
| +0.9% | +$1.33K | 0.01% | 1135 |
|
|
2024
Q4 | $294K | Sell |
23,375
-1,500
| -6% | -$18.9K | 0.01% | 936 |
|
|
2024
Q3 | $459K | Sell |
24,875
-30
| -0.1% | -$554 | 0.01% | 772 |
|
|
2024
Q2 | $536K | Sell |
24,905
-575
| -2% | -$12.4K | 0.02% | 693 |
|
|
2024
Q1 | $686K | Buy |
25,480
+13,610
| +115% | +$367K | 0.02% | 639 |
|
|
2023
Q4 | $356K | Sell |
11,870
-13,910
| -54% | -$417K | 0.03% | 578 |
|
|
2023
Q3 | $528K | Sell |
25,780
-307
| -1% | -$6.29K | 0.02% | 690 |
|
|
2023
Q2 | $518K | Sell |
26,087
-1,508
| -5% | -$30K | 0.02% | 721 |
|
|
2023
Q1 | $473K | Buy |
27,595
+1,275
| +5% | +$21.8K | 0.02% | 819 |
|
|
2022
Q4 | $515K | Hold |
26,320
| – | – | 0.02% | 752 |
|
|
2022
Q3 | $420K | Buy |
26,320
+5,030
| +24% | +$80.3K | 0.02% | 801 |
|
|
2022
Q2 | $293K | Buy |
21,290
+7,230
| +51% | +$99.5K | 0.01% | 997 |
|
|
2022
Q1 | $223K | Buy |
+14,060
| New | +$223K | 0.01% | 1181 |
|